At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 163 enrolled
Drug / intervention
Dexamethasone +1 moredrug
Likely dose
Dexamethasone 0.5 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized, Controlled Trial of Post-operative Steroids and Pain Control After Tonsillectomy
In Brief
A Phase 2 clinical trial evaluating Dexamethasone and Placebo for Tonsillitis and Obstructive Sleep Apnea of Child. Completed, enrolled 163 participants across 1 site.
Detailed Summary
This research study aims to find out if a single oral dose of steroid after tonsillectomy will reduce pain and decrease the need for narcotic medications.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTonsillitis, Obstructive Sleep Apnea of Child
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20192020202120222023202420252026
Enrollment StartDec 2018
First PostedJun 2019
Primary CompletionSep 2025
Study CompletionDec 2025
TodayJul 2026
First PostedJun 24, 2019
Enrollment StartDec 18, 2018
Primary CompletionSep 15, 2025
Study CompletionDec 31, 2025
TodayJul 2, 2026
Enrollment to primary: 6.7 yearsPosted 7.0 years ago
Interventions
Dexamethasonedrug
One dose of dexamethasone (0.5 mg/kg) on post-operative day 3 after tonsillectomy
Placebodrug
One dose of placebo on post-operative day 3 after tonsillectomy